• China Jul 29, 2019

    Pfizer, Mylan Strengthen Ties, Create New Company

    Pfizer, the country’s largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. Pfizer’s Upjohn, which sells one-time blockbusters like Viagra and Lipitor that have lost patent protection, will be spun off and then it will combine with Mylan, a $10 billion company.

  • New Hampshire Feb 7, 2019

    OUI Crash Leaves Pickup Truck Wedged Under Big Rig: Police

    A pickup truck was wedged underneath a big rig early Thursday following a car crash that was the result of an intoxicated driver, according to New Hampshire State Police. Authorities received a report of the crash at 12:55 a.m. on Interstate 95 in Greenland. At the scene, the hood of a 2006 Dodge Dakota was tucked under the semi-truck. An...

  • NBC Aug 22, 2018

    FDA Extends EpiPen Expiration to Cover Shortages

    The Food and Drug Administration said Tuesday that people can use some expired EpiPens for a few months longer to help cover spot shortages that have put some parents into a panic at the beginning of a new school year, NBC News reported. Some batches of the devices, which inject lifesaving medication to stop severe allergic reactions, can be used...

  • Commissioner Aug 16, 2018

    FDA Approves Teva's Generic EpiPen After Yearslong Delay

    U.S. regulators cleared the first generic competitor to Mylan’s EpiPen, after a yearslong delay that many said contributed to the emergency allergy drug’s rapid rise in price. Teva Pharmaceuticals received Food and Drug Administration approval for generic versions of both the EpiPen and EpiPen Jr, the agency said in a statement Tuesday.

  • NBC News May 9, 2018

    What to Do When There Is a Shortage of EpiPens

    The Food and Drug Administration added EpiPens, generic epipens and Adrenaclick autoinjectors to its list of drug shortages. This doesn’t mean people cannot get EpiPens or generics, the FDA said, but they may have to look harder or turn to a different brand, such as Auvi-Q by Kaleo. To stay prepared during the shortage, don’t wait for an emergency and...

  • NBC News May 9, 2018

    EpiPen Shortage Declared by FDA

    The Food and Drug Administration says there is a shortage of EpiPen auto injectors, which are used to treat severe allergic reactions.

  • New Hampshire Aug 19, 2017

    New Hampshire to Get $1M in EpiPen Settlement

    New Hampshire will be getting $1 million from EpiPen maker Mylan as part of a national settlement.

  • United States May 31, 2017

    Taxpayers May Have Overpaid by More Than $1 Billion for Mylan's EpiPen: Senator

    American taxpayers may have overpaid by as much as $1.27 billion for EpiPen anti-allergy devices over the course of a decade, a U.S. senator said Wednesday. That is nearly three times the $465 million that EpiPen’s owner, drugmaker Mylan, last October said it agreed to pay the federal government to settle claims it overcharged the government-run Medicaid system for the...

  • CEO Dec 16, 2016

    Mylan to Offer Generic EpiPen for $300 Next Week

    Mylan is about to start selling a generic version of its EpiPen injector for $300 per two-pack, under half the cost of the name-brand lifesaving drug, the pharmaceutical company announced Friday. The move comes after 20 state attorneys general launched a federal lawsuit alleging that Mylan and five other generic drug-makers artificially inflated and manipulated prices to reduce competition for...

  • United States Dec 8, 2016

    UK Regulators Fine Pfizer Over $100M for Epilepsy Drug Price Hike

    British regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record 89.4 million pounds ($112.7 million) Wednesday for increasing the cost of an epilepsy drug by as much as 2,600 percent. Pfizer and Flynn Pharma charged “excessive and unfair prices” for the drug used by 48,000 people in Britain, the Competition and Markets Authority said. Pfizer was fined 84.2...

  • NBC Sep 30, 2016

    Experts Looked Inside Mylan's Upgraded EpiPen

    With Congress trying to figure out Mylan’s business model for the EpiPen, a medical technologies expert and a Seattle doctor have been physically taking apart the auto-injectors to find out exactly how the device has changed since Mylan acquired it, NBC News reported. Mylan CEO Heather Bresch testified last week that it invested more than $1 billion enhancing the product,...

  • NBC Sep 6, 2016

    Industry Insiders Estimate EpiPen Costs No More Than $30

    Mylan says middlemen and suppliers have forced them to jack up the prices on EpiPens by hundreds of dollars, but two industry insiders say the company pays no more than $30 per device, NBC News reports. Some patients are forced to pay a little over $600 out of pocket for a two-pack of the lifesaving medication. Mylan sparked outrage last...

  • NBC Aug 18, 2016

    EpiPen Price Hike Has Parents of Kids With Allergies Scrambling Ahead of School Year

    Doctors and patients say the pharmaceutical company Mylan has increased the prices for an EpiPen — the portable device that can stop a potentially life-threatening allergic reaction — from around $100 in 2008 to $500 or more today, NBC News reports. Following a recall by Mylan’s chief competitor last year, the company now enjoys a near monopoly. EpiPens have a...

  • Paris Apr 26, 2016

    Company Recalls Hundreds of Thousands of Epinephrine Injection Pens Used to Treat Severe Allergies

    Sanofi is recalling hundreds of thousands of epinephrine injectors used to treat severe allergic reactions because they may not deliver the correct amount of the life-saving drug.

Contact Us